CA 19-9 in pancreatic cancer

R. E. Ritts, H. A. Pitt

Research output: Contribution to journalReview article

Abstract

CA 19-9 has achieved a defined role in the diagnosis, prognosis, and monitoring of patients with pancreatic cancer. For diagnosis, a reference value above 200 u/mL in a nonjaundiced patient with a confirming CT scan has a very high predictive value. For prognosis, a low preoperative value and a normal value after resection predict a good outcome. Similarly, CA 19-9 levels have been used successfully in monitoring the response to neoadjuvant therapy.

Original languageEnglish (US)
Pages (from-to)93-101
Number of pages9
JournalSurgical Oncology Clinics of North America
Volume7
Issue number1
StatePublished - Mar 24 1998

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'CA 19-9 in pancreatic cancer'. Together they form a unique fingerprint.

  • Cite this

    Ritts, R. E., & Pitt, H. A. (1998). CA 19-9 in pancreatic cancer. Surgical Oncology Clinics of North America, 7(1), 93-101.